Alumis

alumis.com

Alumis Inc. is dedicated to transforming the treatment of immune-mediated diseases through a precision approach to drug development. The company focuses on creating targeted oral therapies that aim to replace broad immunosuppression with more effective treatments, addressing the unmet needs of patients who suffer from debilitating conditions. With a robust pipeline of molecules and a commitment to leveraging genetic and translational insights, Alumis is positioned to optimize therapeutic outcomes and significantly improve patient lives. Their experienced leadership team, incubated by Foresite Labs, brings a proven track record in drug development, making Alumis a promising player in the biopharmaceutical landscape.